CanaQuest Medical Corp CANQF

Biotechnology

CanaQuest Medical Corp is a Canada-based clinical-stage, life sciences company. The Company is focused on the drug discovery and development of targeted therapeutics within the endocannabinoidome, including PPAR receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and post-traumatic stress disorder (PTSD). It has created a natural formulation derived from cannabidiol + proprietary API composition. The Company has a drug candidate, CQ-001, positioned for clinical trials targeting epilepsy. Its CQ-001 drug candidate combines cannabidiol (CBD) with essential fatty acids (Omega-3s). In addition, the Company is also focused on developing a nutraceutical version of the formulation, Mentanine, which is scheduled for clinical studies to investigate its potential applications across various indications, paving the way for future clinical trials.

OTCPK:CANQF - Post by User

CanaQuest Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by AveragePennyon Mar 29, 2021 9:50am

82 Views

Post# 32897536

$CANQF CanaQuest Medical Corp Honored With International CBD

https://www.accesswire.com/637829/CanaQuest-Medical-Corp-Honored-With-International-CBD-Life-Science-R-D-Excellence-Award-2020-by-Global-Health-Pharma

TORONTO, ON / ACCESSWIRE / March 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma, United Kingdom, a global information sharing platform & multi-disciplinary members community.

User image